Renal impairment a neglected comorbidity in patients with COPD

Mohit Bhatia (Ghaziabad, India), Mohit Bhatia, J.K. Samaria, Shubham Agarwal, Pradeep Nirala

Source: International Congress 2016 – Monitoring comorbidities
Session: Monitoring comorbidities
Session type: Thematic Poster
Number: 4155
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mohit Bhatia (Ghaziabad, India), Mohit Bhatia, J.K. Samaria, Shubham Agarwal, Pradeep Nirala. Renal impairment a neglected comorbidity in patients with COPD. Eur Respir J 2016; 48: Suppl. 60, 4155

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of comorbidities in COPD prognosys scores
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


The severity of anxiety in COPD patients (pts)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014


The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013


Comorbidities in patients with COPD and their impact on COPD course
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

The distribution of phenotypes in a population of severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014



Comorbidity in patients with COPD in Russia
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014


The role of COPD in development of osteoporosis
Source: International Congress 2014 – Markers
Year: 2014


Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015

COPD as undetected cause of dyspnea in patients admitted with ischaemic heart disease (IHD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


COPD and depression: Prevalence and interaction
Source: International Congress 2014 – Comorbidities
Year: 2014


Relationship between dyspnea and depression in the elderly patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

The most frequent comorbidies in COPD and their inflence on the prognosis of the disease
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013

Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations
Source: International Congress 2014 – COPD markers
Year: 2014


Severity of airflow obstruction and multicomponent disease staging of COPD in the real-world primary care in Greece: The AEOLUS study
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


Cardiovascular status of patients with a severe form of COPD
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015


Cognitive dysfunction is greater in patients hospitalised with COPD exacerbations than with worsening heart failure
Source: International Congress 2014 – Markers
Year: 2014


COPD on anti-GERD therapy remains at higher risk for severe exacerbation
Source: International Congress 2014 – COPD exacerbations
Year: 2014